Wonbiogen Statistics

Total Valuation

Wonbiogen has a market cap or net worth of KRW 37.57 billion. The enterprise value is 27.65 billion.

Market Cap	37.57B
Enterprise Value	27.65B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Wonbiogen has 35.47 million shares outstanding. The number of shares has decreased by -6.20% in one year.

Current Share Class	n/a
Shares Outstanding	35.47M
Shares Change (YoY)	-6.20%
Shares Change (QoQ)	-6.81%
Owned by Insiders (%)	32.42%
Owned by Institutions (%)	n/a
Float	23.97M

Valuation Ratios

The trailing PE ratio is 6.62.

PE Ratio	6.62
Forward PE	n/a
PS Ratio	1.24
PB Ratio	1.01
P/TBV Ratio	1.03
P/FCF Ratio	4.58
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.50, with an EV/FCF ratio of 3.37.

EV / Earnings	4.86
EV / Sales	0.91
EV / EBITDA	3.50
EV / EBIT	4.42
EV / FCF	3.37

Financial Position

The company has a current ratio of 6.55, with a Debt / Equity ratio of 0.02.

Current Ratio	6.55
Quick Ratio	4.77
Debt / Equity	0.02
Debt / EBITDA	0.11
Debt / FCF	0.11
Interest Coverage	107.61

Financial Efficiency

Return on equity (ROE) is 15.28% and return on invested capital (ROIC) is 9.95%.

Return on Equity (ROE)	15.28%
Return on Assets (ROA)	9.23%
Return on Invested Capital (ROIC)	9.95%
Return on Capital Employed (ROCE)	16.37%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.72
Inventory Turnover	2.57

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-43.27%
50-Day Moving Average	1,118.42
200-Day Moving Average	1,324.39
Relative Strength Index (RSI)	22.98
Average Volume (20 Days)	54,745

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Wonbiogen had revenue of KRW 30.44 billion and earned 5.69 billion in profits. Earnings per share was 160.00.

Revenue	30.44B
Gross Profit	14.24B
Operating Income	6.22B
Pretax Income	6.42B
Net Income	5.69B
EBITDA	7.86B
EBIT	6.22B
Earnings Per Share (EPS)	160.00

Full Income Statement

Balance Sheet

The company has 10.87 billion in cash and 892.23 million in debt, giving a net cash position of 9.98 billion or 281.29 per share.

Cash & Cash Equivalents	10.87B
Total Debt	892.23M
Net Cash	9.98B
Net Cash Per Share	281.29
Equity (Book Value)	37.27B
Book Value Per Share	1,048.88
Working Capital	18.35B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.85 billion and capital expenditures -648.41 million, giving a free cash flow of 8.20 billion.

Operating Cash Flow	8.85B
Capital Expenditures	-648.41M
Free Cash Flow	8.20B
FCF Per Share	231.19

Full Cash Flow Statement

Margins

Gross margin is 46.78%, with operating and profit margins of 20.42% and 18.69%.

Gross Margin	46.78%
Operating Margin	20.42%
Pretax Margin	21.10%
Profit Margin	18.69%
EBITDA Margin	25.83%
EBIT Margin	20.42%
FCF Margin	26.94%

Dividends & Yields

This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 1.91%.

Dividend Per Share	20.00
Dividend Yield	1.91%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	12.46%
Buyback Yield	6.20%
Shareholder Yield	8.11%
Earnings Yield	15.15%
FCF Yield	21.83%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Wonbiogen has an Altman Z-Score of 11.

Altman Z-Score	11
Piotroski F-Score	n/a